Posted by europerep on October 20, 2011, at 15:30:27
In reply to Re: opiates and major depression » europerep, posted by Chairman_MAO on October 19, 2011, at 13:50:09
My point was simply this: pharmacology matters.
It matters when explaining to a doctor why giving buprenorphine to a patient with TRD is not like prescribing morphine, or for that matter, heroin. It matters when trying to point out why the risk-benefit ratio with buprenorphine is better than with oxycodone or hydromorphone. And lastly, it matters when looking at what future drug treatments could or should look like.
That's all I wanted to say.
poster:europerep
thread:81414
URL: http://www.dr-bob.org/babble/20111016/msgs/1000328.html